IL-8 signaling is up-regulated in alcoholic hepatitis and DDC fed mice with Mallory Denk Bodies (MDBs) present

Experimental and Molecular Pathology

Volumn 99, Issue 2, 2015, Pages 320-325

  Liu, Hui ^a   French, Barbara A ^a   Nelson, Tyler J ^a   Li, Jun ^a   Tillman, Brittany ^a   French, Samuel W ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

Alcoholic hepatitis; CXCR2; IL 8 signaling; Mallory Denk bodies

Indexed keywords

CHEMOKINE RECEPTOR CXCR2; DICARBOXYLIC ACID; DIETHYL 1,4 DEHYDRO 2,4,6 TRIMETHYL 3,5 PYRIDINE DICARBOXYLATE; INTERLEUKIN 8; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BAX; PROTEIN BCL 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; UNCLASSIFIED DRUG; 3,5-DIETHOXYCARBONYL-1,4-DIHYDROCOLLIDINE; BIOLOGICAL MARKER; PYRIDINE DERIVATIVE;

ALCOHOL LIVER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CXCR2 GENE; GENE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IL 8 GENE; INTRACELLULAR SIGNALING; LIVER BIOPSY; MALE; MALLORY BODY; MALLORY DENK BODY; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; RNA SEQUENCE; TRANSCRIPTION REGULATION; UPREGULATION; ANIMAL; C3H MOUSE; CELL CULTURE; COMPARATIVE STUDY; CYTOLOGY; ENZYME IMMUNOASSAY; GENE EXPRESSION PROFILING; GENETICS; HEPATITIS, ALCOHOLIC; HIGH THROUGHPUT SEQUENCING; LIVER; LIVER CELL; METABOLISM; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

MUS;

ANIMALS; BIOMARKERS; BLOTTING, WESTERN; CELLS, CULTURED; GENE EXPRESSION PROFILING; HEPATITIS, ALCOHOLIC; HEPATOCYTES; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; IMMUNOENZYME TECHNIQUES; INTERLEUKIN-8; LIVER; MALE; MALLORY BODIES; MICE; MICE, INBRED C3H; PYRIDINES; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84939481532     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2015.08.002     Document Type: Article

References (35)

1. Aggarwal B.B., Sung B. NF-kappaB in cancer: a matter of life and death. Cancer Discov. 2011, 1:469-471.
2. Basaranoglu M., et al. Mallory-Denk Bodies in chronic hepatitis. World J. Gastroenterol. 2011, 17:2172-2177.
3. Fernandes A.F., et al. Oxidative inactivation of the proteasome in retinal pigment epithelial cells. A potential link between oxidative stress and up-regulation of interleukin-8. J. Biol. Chem. 2008, 283:20,745-20,753.
4. French B.A., et al. Mallory-Denk bodies form when EZH2/H3K27me3 fails to methylate DNA in the nuclei of human and mice liver cells. Exp. Mol. Pathol. 2012, 92:318-326.
5. French S.W., et al. Mallory-Denk body pathogenesis revisited. World J. Hepatol. 2010, 2:295-301.
6. French S.W., et al. The role of innate immunity in the pathogenesis of preneoplasia in drug-induced chronic hepatitis based on a mouse model. Exp. Mol. Pathol. 2011, 91:653-659.
7. Freund A., et al. Mechanisms underlying differential expression of interleukin-8 in breast cancer cells. Oncogene 2004, 23:6105-6114.
8. Gales D., et al. The chemokine CXCL8 in carcinogenesis and drug response. ISRN Oncol. 2013, 2013:859,154.
9. Gao Y., et al. FAT10, an ubiquitin-like protein, confers malignant properties in non-tumorigenic and tumorigenic cells. Carcinogenesis 2014, 35:923-934.
10. Haybaeck J., et al. Genetic background effects of keratin 8 and 18 in a DDC-induced hepatotoxicity and Mallory-Denk body formation mouse model. Lab. Investig. 2012, 92:857-867.
11. Huang C.Y., et al. Stromal cell-derived factor-1/CXCR4 enhanced motility of human osteosarcoma cells involves MEK1/2, ERK and NF-kappaB-dependent pathways. J. Cell. Physiol. 2009, 221:204-212.
12. Ivison S.M., et al. Oxidative stress enhances IL-8 and inhibits CCL20 production from intestinal epithelial cells in response to bacterial flagellin. Am. J. Physiol. Gastrointest. Liver Physiol. 2010, 299:G733-G741.
13. Lane H.C., et al. Cbl and Akt regulate CXCL8-induced and CXCR1- and CXCR2-mediated chemotaxis. Int. Immunol. 2006, 18:1315-1325.
14. Li B., Dewey C.N. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinf. 2011, 12:323.
15. Li J., et al. S-adenosylmethionine prevents Mallory Denk body formation in drug-primed mice by inhibiting the epigenetic memory. Hepatology 2008, 47:613-624.
16. Li M.Q., et al. CXCL8 enhances proliferation and growth and reduces apoptosis in endometrial stromal cells in an autocrine manner via a CXCR1-triggered PTEN/AKT signal pathway. Hum. Reprod. 2012, 27:2107-2116.
17. Liu H., et al. Mallory-Denk Body (MDB) formation modulates ufmylation expression epigenetically in alcoholic hepatitis (AH) and non-alcoholic steatohepatitis (NASH). Exp. Mol. Pathol. 2014, 97:477-483.
18. Liu H., et al. Ufmylation and FATylation pathways are downregulated in human alcoholic and nonalcoholic steatohepatitis, and mice fed DDC, where Mallory-Denk bodies (MDBs) form. Exp. Mol. Pathol. 2014, 97:81-88.
19. Liu H., et al. TLR3/4 signaling is mediated via the NFkappaB-CXCR4/7 pathway in human alcoholic hepatitis and non-alcoholic steatohepatitis which formed Mallory-Denk bodies. Exp. Mol. Pathol. 2014, 97:234-240.
20. Lukasiak S., et al. Proinflammatory cytokines cause FAT10 upregulation in cancers of liver and colon. Oncogene 2008, 27:6068-6074.
21. Luppi F., et al. Interleukin-8 stimulates cell proliferation in non-small cell lung cancer through epidermal growth factor receptor transactivation. Lung Cancer 2007, 56:25-33.
22. MacManus C.F., et al. Interleukin-8 signaling promotes translational regulation of cyclin D in androgen-independent prostate cancer cells. Mol. Cancer Res. 2007, 5:737-748.
23. Matsushima K., et al. Interleukin-8 and MCAF: novel leukocyte recruitment and activating cytokines. Chem. Immunol. 1992, 51:236-265.
24. Oliva J., et al. Fat10 is an epigenetic marker for liver preneoplasia in a drug-primed mouse model of tumorigenesis. Exp. Mol. Pathol. 2008, 84:102-112.
25. Oliva J., et al. Betaine prevents Mallory-Denk body formation in drug-primed mice by epigenetic mechanisms. Exp. Mol. Pathol. 2009, 86:77-86.
26. Oliva J., et al. The role of cytokines in UbD promoter regulation and Mallory-Denk body-like aggresomes. Exp. Mol. Pathol. 2010, 89:1-8.
27. Patel P.S., et al. Regulation of constitutive and induced NF-kappaB activation in malignant melanoma cells by capsaicin modulates interleukin-8 production and cell proliferation. J. Interf. Cytokine Res. 2002, 22:427-435.
28. Ren J., et al. FAT10 mediates the effect of TNF-alpha in inducing chromosomal instability. J. Cell Sci. 2011, 124:3665-3675.
29. Rollins B.J. Where the confusion began: cloning the first chemokine receptors. J. Immunol. 2009, 183:2893-2894.
30. Singh J.K., et al. Recent advances reveal IL-8 signaling as a potential key to targeting breast cancer stem cells. Breast Cancer Res. 2013, 15:210.
31. Sparmann A., Bar-Sagi D. Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. Cancer Cell 2004, 6:447-458.
32. Tarnowski M., et al. Regulation of expression of stromal-derived factor-1 receptors: CXCR4 and CXCR7 in human rhabdomyosarcomas. Mol. Cancer Res. 2010, 8:1-14.
33. Vandercappellen J., et al. The role of CXC chemokines and their receptors in cancer. Cancer Lett. 2008, 267:226-244.
34. Yuan Q.X., et al. Mallory body induction in drug-primed mouse liver. Hepatology 1996, 24:603-612.
35. Zhang D.W., et al. p53 negatively regulates the expression of FAT10, a gene upregulated in various cancers. Oncogene 2006, 25:2318-2327.